Sihuan Pharma grants 116,150,000 share awards under 2026 incentive scheme at HK$ 0.74 each

• Sihuan Pharmaceutical launched a 2026 share award grant covering 116,150,000 shares, about 1.27% of issued shares excluding treasury.
• Grant date set for Sept. 1, 2026, with a purchase price of HK$ 0.74 per share, matching the closing price.
• Vesting planned over five years, starting no earlier than 12 months post-grant, with 20% scheduled to vest each September.
• Allocation included 6,000,000 shares to executive director Chen Yanling, 3,000,000 to Che Yutong, balance to employees.
• 796,448,820 shares remained available for future awards under the scheme mandate limit as of the announcement date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260901-12314335), on September 01, 2026, and is solely responsible for the information contained therein.